Alector (ALEC) Capital Expenditures (2018 - 2026)
Alector's (ALEC) quarterly Capital Expenditures came in at $31000.0 in Q2 2026, up 210.0% year-over-year from $10000.0 in Q2 2025, and down 73.73% quarter-over-quarter from $118000.0 in Q1 2026.
Analysis
Alector (ALEC) Capital Expenditures (2018 - 2026) Analysis & Trends
Alector (ALEC) has reported Capital Expenditures for 9 consecutive years, with $31000.0 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Capital Expenditures rose 210.0% year-over-year to $31000.0 in Q2 2026; TTM through Jun 2026 was $160000.0, a 61.45% decrease from a year earlier, with the FY2025 full-year figure at $41000.0, down 96.73% from the prior year.
- Capital Expenditures was $31000.0 for Q2 2026 at Alector, down from $118000.0 in the prior quarter.
- Over five years, Capital Expenditures peaked at $1.9 million in Q3 2022 and troughed at -$94000.0 in Q3 2023.
- A 5-year average of $467235.3 and a median of $233000.0 in 2023 frame the typical range for Capital Expenditures.
- Across the five-year window, Capital Expenditures slumped 104.91% in 2023 and jumped 490.0% in 2026, its largest moves.
- Over 5 years, Capital Expenditures stood at $766000.0 in 2022, then tumbled by 69.58% to $233000.0 in 2023, then decreased by 25.75% to $173000.0 in 2024, then slumped by 93.64% to $11000.0 in 2025, then surged by 181.82% to $31000.0 in 2026.
- The last three Capital Expenditures figures came in at $31000.0 (Q2 2026), $118000.0 (Q1 2026), and $11000.0 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn | 513.00 Mn |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn | 140.00 Mn |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn | 112.20 Mn |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn | 240.20 Mn |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn | - |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn | 37.00 Mn |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn | 34.68 Mn |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn | 40.90 Mn |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn | 6.26 Mn |
| 10 | Alector | 274.68 Mn | 101.88 Mn | - | 31,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 31,000.00 |
| Mar 31, 2026 | 118,000.00 |
| Sep 30, 2025 | 11,000.00 |
| Jun 30, 2025 | 10,000.00 |
| Mar 31, 2025 | 20,000.00 |
| Dec 31, 2024 | 173,000.00 |
| Sep 30, 2024 | 212,000.00 |
| Jun 30, 2024 | 337,000.00 |
| Mar 31, 2024 | 533,000.00 |
| Dec 31, 2023 | 233,000.00 |
| Sep 30, 2023 | -94,000.00 |
| Jun 30, 2023 | 1.22 Mn |
| Mar 31, 2023 | 1.03 Mn |
| Dec 31, 2022 | 766,000.00 |
| Sep 30, 2022 | 1.92 Mn |
| Jun 30, 2022 | 744,000.00 |
| Mar 31, 2022 | 692,000.00 |
| Dec 31, 2021 | 557,000.00 |
| Sep 30, 2021 | 915,000.00 |
| Jun 30, 2021 | 828,000.00 |